Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.8 |
mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |